By Rob Crandall / Shutterstock.com

Coronavirus Roundup: Union and EPA Dispute Conditions for Returning to the Office; Ousted Vaccine Director Amends Whistleblower Complaint 

There's a lot to keep track of. Here’s today’s list of news updates and stories you may have missed.

On Thursday, the Centers for Disease Control and Prevention expanded its list of individuals who are at high risk of getting severely ill from the novel coronavirus. In addition to adding pre-existing medical conditions that could lead to more vulnerability to the virus, it removed the age-specific threshold. “Risk increases steadily as you age, and it’s not just those over the age of 65 who are at increased risk for severe illness,” said the agency. Here are some other recent headlines you might have missed. 

The Government Accountability Office published a report on Thursday that said the costs for the Fourth of July events on the National Mall were between $6 million-$7 million annually from 2016 to 2018 and more than $13 million in 2019. Sens. Chris Van Hollen, D-Md.; Tom Udall, D-N.M.; and Patrick Leahy, D-Vt., who requested the report, would now like GAO to review President Trump’s plans for this year, which include a firework display over Mount Rushmore in South Dakota. In addition to concerns over how taxpayer funds will be spent, “We question whether large, ticketed public events can be conducted safely and in a manner that is consistent with guidance from the federal Centers for Disease Control and Prevention and other state and local public health authorities,” they wrote. “We also believe that appropriate action must be taken to protect the health and welfare of members of the public who attend public gatherings as well as the federal, state and local government employees and other essential workers who will be required to participate.”

Dr. Rick Bright, the ousted federal vaccine director, amended his whistleblower complaint to claim that Health and Human Services Secretary Alex Azar said, "If anyone were to help Dr. Bright be successful, 'there would be hell to pay.' " Bright was demoted to a role at the National Institutes of Health. Bright’s new allegation says that Dr. Gary Disbrow, his acting replacement at the Biomedical Advanced Research and Development Authority, told an HHS employee about Azar’s remark. Disbrow denied all of the claims, CBS reported.

On Thursday, NBC reported on an internal document from the White House coronavirus task force that details the surges of coronavirus cases around the country. On Tuesday, Trump said the virus is “going away” an event in Phoenix, “but on the same day, the coronavirus task force produced an internal document showing that Phoenix had the highest number of new cases among the 10 metropolitan regions where the week-over-week change in infection rates spiked the most,” NBC reported. The “mixed signals” from the Trump administration have created much confusion and uncertainty for state and local officials. 

New estimates from the Centers for Disease Control and Prevention show that the true number of coronavirus cases in the United States might be 10 times higher than previously recorded. “This virus causes so much asymptomatic infection," CDC Director Dr. Robert Redfield said on Thursday. "The traditional approach of looking for symptomatic illness and diagnosing it obviously underestimates the total amount of infections," NBC reported

On Friday, Rep. Frank Pallone Jr., D-N.J., chairman of the House Energy and Commerce Committee, asked HHS to provide Congress with the coronavirus testing plans that states were required to submit to the department under the Paycheck Protection Program and Health Care Enhancement Act. “I continue to strongly believe that a national testing strategy, coordinated and spearheaded by the federal government, is the most effective approach to ensuring our nation has adequate testing capacity to respond to COVID-19,” wrote Pallone. “Given this administration’s deference to states and localities, it is even more critical that these testing plans be made public in order for Congress and the American people to review and analyze the testing efforts underway at the state and local level.”

Sen. Maggie Hassan, D-N.H., led a group of Democrats in asking HHS for information on how the administration plans to replenish the Strategic National Stockpile as public health experts anticipate a second wave of the coronavirus in the fall, Politico reported on Friday. 

White House Deputy Domestic Policy Adviser Maria Bonner is leaving the administration, according to those familiar with her decision, Politico reported. Former Domestic Policy Council Chief Joe Grogan told Politico that Bonner was an "integral part of the health team."

Retired Gen. Joseph Dunford is the leading choice of Senate Majority Leader Mitch McConnell, R-Ky., and House Speaker Nancy Pelosi, D-Calif., to chair the congressional coronavirus oversight commission, according to Politico. Dunford was the chairman of the Joint Chiefs of Staff under the Obama and Trump administrations; he started his military career in 1978.

Following the GAO report that said the Internal Revenue Service and Treasury Department distributed almost 1.1 million relief payments totaling nearly $1.4 billion to deceased individuals, the top Senate Democrat called for more oversight. “Where's the Republican oversight? This is a $3 trillion package. And every small bit of oversight that the Republicans have done has had to be pushed by Democrats,” said Senate Minority Leader Chuck Schumer, D-N.Y., in a statement to the press. “We should be having far more robust oversight over what has happened, as well as moving forward on a new bill.”

Politico looked at the legal aspects of how and why dead people received checks. GAO said: “IRS counsel subsequently determined that IRS did not have the legal authority to deny payments to those who filed a return in 2019 [and 2018], even if they were deceased at the time of payment.” However, an anonymous Treasury official gave Politico a “conflicting account,” saying the department wasn't aware of the problem “until it was reported in various media outlets” in the spring. 

The American Federation of Government Employees and the Environmental Protection Agency are in a dispute over the process to return employees back to offices. “It is troubling that AFGE continues to misrepresent the agency’s communications,” wrote Nicole Patterson, acting director of EPA’s Labor and Employee Relations Division. “Despite the numerous briefings, demonstrations and resources provided by the agency, AFGE conveys ignorance about the agency’s plans for reopening. Most concerning, the union’s persistent and recent misrepresentations are stoking fear in employees about returning to the workplace...We urge AFGE to devote time to ensuring local representatives and bargaining units are equally and factually informed. In these difficult and unprecedented times, communication and cooperation are paramount. While we will continue to communicate and cooperate with AFGE, we hope to see improved communications and cooperation within AFGE.” 

On Thursday, AFGE sent a statement to the press in response. “While it is true that EPA has given us notice and is apparently planning to bargain with us, what is also true is that they have moved ahead without completing those negotiations – rushing to reopen offices with little regard to the health and safety of employees,” said the union. “Agency briefings are not the same as formal negotiations with the union. EPA is enforcing its plans for reopening worksites without satisfying its legal obligations to negotiate the impact of those changes with AFGE. Our claims are not false. We have and will continue to pursue litigation against the agency in every instance in which they violate the law.”

Mark Morgan, acting Customs and Border Protection commissioner, gave conflicting testimony on Thursday about the agency’s screening procedure for unaccompanied children at the Southern border. He “testified that all of the children were screened to make sure they didn’t potentially qualify for asylum,” Roll Call reported. However in his written testimony submitted before the hearing, he said that “initial asylum screenings on unaccompanied minors have been conducted only on a case-by-case basis, ‘when it is not possible to return a minor to his or her home country or when an agent or officer suspects trafficking or sees signs of illness.’ ” In March, the Trump administration used a public health directive to allow CBP officials to deny entry to migrants at the border who would have otherwise been allowed in. 

Morgan said 2,000 unaccompanied minors have been turned away since March. “CBP works extensively with the governments of the countries that they are being returned to, to make sure that they are returned in a safe and humane, compassionate way, and that they are actually reunited with their parents in their home country,” Morgan said. Yet, CBP doesn't track if the minors make it back to their original homes, Roll Call reported. 

Help us understand the situation better. Are you a federal employee, contractor or military member with information, concerns, etc. about how your agency is handling the coronavirus? Email us at newstips@govexec.com.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.